DBV Technologies | Zysk Brutto Na Sprzedaży



Gross Profit On Sales Zmiana Data
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amarin USD 16.28M 26.49M 2024-09
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
DBV Technologies -30442000 30.56M 2024-09
Halozyme Therapeutics USD 216.46M 39.49M 2025-03
Incyte USD 985.09M 111.22M 2025-03
Insmed USD 71.54M 6.75M 2025-03
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
United Therapeutics USD 701.9M 41.9M 2025-03



DBV Technologies Zysk Brutto Na Sprzedaży - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.